Company Overview
Snapshot
Founded in January 2007 by Uri Rapoport, Aspect Imaging operates with 51–200 employees and has raised a total of $50 million across two funding rounds from two investors. The company received FDA clearance for its Embrace Neonatal MRI system in July 2017, marking a significant milestone in its medical device development.
Business overview
Aspect Imaging develops compact MRI and NMR systems utilizing permanent magnets for preclinical, medical, and advanced industrial applications. The company's technology platform supports products such as the Embrace Neonatal MRI system and WristView point-of-care hand and wrist MRI system for the medical market, and the M-series compact MRI for preclinical research. Additionally, Aspect Imaging provides industrial solutions like the Flowscan for rheological analysis and the AI-60 NMR for real-time stream analysis of dense materials in sectors including oil and gas.
Strategic signal
In December 2018, Aspect Imaging highlighted its Embrace Neonatal MRI System as a groundbreaking solution for providing MRI capabilities inside the NICU. This development underscores the company's commitment to advancing medical imaging technology for vulnerable populations and signals its potential to transform neonatal care by making advanced diagnostics more accessible.
Log in to access full profile ›Company Intelligence Q&A
- What is Aspect Imaging's primary focus in the medical market?
- Aspect Imaging focuses on developing compact MRI systems for medical applications, including the Embrace Neonatal MRI system and the WristView point-of-care hand and wrist MRI system, both of which are in full production. A dedicated Stroke MRI for the ER is also under development.
- When did Aspect Imaging receive FDA clearance for its Embrace Neonatal MRI System?
- In July 2017, Aspect Imaging announced FDA clearance for its Embrace Neonatal MRI System, designed for use in the Neonatal Intensive Care Unit (NICU).
- What industrial applications does Aspect Imaging's technology support?
- Aspect Imaging's technology supports advanced industrial applications such as rheological analysis of food products and industrial drilling mud with its Flowscan, and real-time, continuous flow-through stream analysis of dense and opaque materials like crude oil, HF, and silicon production using its AI-60 NMR.
- What was a key development for the Embrace Neonatal MRI System in late 2017?
- In November 2017, Aspect Imaging received CE Mark approval for its Embrace Neonatal MRI System, allowing its use in the NICU within the European market.
- Who are the founders of Aspect Imaging?
- Aspect Imaging was founded by Uri Rapoport, who also serves as President & CEO.